electroCore (NASDAQ:ECOR) Given New $25.00 Price Target at HC Wainwright

electroCore (NASDAQ:ECOR) had its price objective lifted by HC Wainwright from $22.00 to $25.00 in a research report sent to investors on Wednesday,Benzinga reports. They currently have a buy rating on the stock. HC Wainwright also issued estimates for electroCore’s FY2026 earnings at $0.52 EPS, FY2027 earnings at $1.34 EPS and FY2028 earnings at $2.24 EPS.

electroCore Stock Down 2.7 %

ECOR traded down $0.42 during midday trading on Wednesday, reaching $15.05. 174,309 shares of the company’s stock were exchanged, compared to its average volume of 36,274. The business has a 50-day simple moving average of $11.38 and a two-hundred day simple moving average of $8.07. The firm has a market capitalization of $98.65 million, a price-to-earnings ratio of -8.22 and a beta of 0.57. electroCore has a one year low of $5.25 and a one year high of $17.84.

Institutional Trading of electroCore

Large investors have recently bought and sold shares of the stock. HighTower Advisors LLC bought a new position in shares of electroCore during the third quarter valued at $255,000. International Assets Investment Management LLC increased its position in shares of electroCore by 27.9% during the 2nd quarter. International Assets Investment Management LLC now owns 67,820 shares of the company’s stock worth $436,000 after purchasing an additional 14,800 shares in the last quarter. Renaissance Technologies LLC lifted its holdings in electroCore by 3.4% during the 2nd quarter. Renaissance Technologies LLC now owns 68,786 shares of the company’s stock valued at $442,000 after purchasing an additional 2,270 shares during the last quarter. Finally, Geode Capital Management LLC lifted its holdings in electroCore by 10.3% during the 3rd quarter. Geode Capital Management LLC now owns 63,485 shares of the company’s stock valued at $458,000 after purchasing an additional 5,951 shares during the last quarter. 26.74% of the stock is currently owned by institutional investors.

About electroCore

electroCore, Inc, a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania.